Addex Therapeutics News

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Aug 14 20:15 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(5.1%),New Enterprise Associates 15, L.P.(5.1%), etc.

Aug 5 21:03 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(6.4%),New Enterprise Associates 15, L.P.(6.4%), etc.

Dec 8, 2023 14:11 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy Mark Dyer(14.16%)

Nov 29, 2023 16:00 ET

Addex Therapeutics | D: Filing D

Apr 13, 2023 08:14 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(8.5%),New Enterprise Associates 15, L.P.(8.5%), etc.

Apr 10, 2023 16:06 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy Mark Dyer(11.09%)

Apr 5, 2023 16:00 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy Mark Dyer(12.18%)

Mar 31, 2023 16:00 ET

Addex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)

Feb 16, 2023 14:49 ET

Addex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caxton Corporation(0.9%),CDK Associates, L.L.C.(0.9%), etc.

Feb 14, 2023 12:30 ET

Addex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.97%),Steven Boyd(4.97%)

Feb 14, 2023 11:53 ET

Addex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(0.0 %),GOLDMAN SACHS & CO. LLC(0.0 %)

Feb 7, 2023 18:08 ET

Addex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Leaf Biopharma Opportunities I, L.P.(3.0%),New Leaf BPO Associates I, L.P.(3.0%), etc.

Feb 6, 2023 16:32 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(9.7%),New Enterprise Associates 15, L.P.(9.7%), etc.

Nov 28, 2022 15:19 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy Mark Dyer(13.54%)

Nov 23, 2022 06:00 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy Mark Dyer(20.01%)

Nov 9, 2022 16:00 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%), etc.

Aug 23, 2022 17:18 ET

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Timothy Mark Dyer(8.40%)

Aug 5, 2022 06:01 ET

Addex Therapeutics | D: Filing D

Aug 4, 2022 12:30 ET

Addex Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Leaf Biopharma Opportunities I, L.P.(6.2%),New Leaf BPO Associates I, L.P.(6.2%), etc.

Feb 18, 2022 16:54 ET